Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1997-7-7
|
pubmed:abstractText |
The effect of intragastrically or parenterally administered beta-glucan, extracted from oats, on the enhancement of disease resistance to Eimeria vermiformis was studied in C57BL/6 mice. Groups of mice were immunosuppressed with dexamethasone (DXM), infected with oocysts of E. vermiformis and treated with oat beta-glucan by the intragastric (i.g.) or subcutaneous (s.c.) routes. Faecal oocyst shedding was reduced in the beta-glucan-treated groups compared to the non-treated group. Immunosuppressed mice which received no beta-glucan treatment showed more severe clinical signs of the disease and a 50% mortality, while minimal clinical signs and no mortality were recorded in the beta-glucan-treated groups. Total IgG, IgG1, IgG2a, IgM and IgA immunoglobulins in the serum of beta-glucan-treated groups were overall higher than those in the non-treated group. Specific IgG anti-sporozoite and merozoite immunoglobulins in serum were significantly higher in the beta-glucan-treated groups than in the non-treated animals. No significant differences were found in the levels of intestinal IgA anti-sporozoite and anti-merozoite immunoglobulins. IFN-gamma- and IL-4-secreting cells, in response to sporozoite antigen, were detected in the spleen and mesenteric lymph nodes of the beta-glucan-treated groups only. In conclusion, the i.g. and s.c. oat beta-glucan treatment increased the resistance to E. vermiformis infection in immunosuppressed mice.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adjuvants, Immunologic,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Protozoan,
http://linkedlifedata.com/resource/pubmed/chemical/Dexamethasone,
http://linkedlifedata.com/resource/pubmed/chemical/Glucans,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin A,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin G,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin M,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-gamma,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-4,
http://linkedlifedata.com/resource/pubmed/chemical/beta-Glucans,
http://linkedlifedata.com/resource/pubmed/chemical/beta-glucan, (1-3)(1-4)-
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0020-7519
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
329-37
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:9138036-Adjuvants, Immunologic,
pubmed-meshheading:9138036-Animals,
pubmed-meshheading:9138036-Antibodies, Protozoan,
pubmed-meshheading:9138036-Coccidiosis,
pubmed-meshheading:9138036-Dexamethasone,
pubmed-meshheading:9138036-Eimeria,
pubmed-meshheading:9138036-Female,
pubmed-meshheading:9138036-Glucans,
pubmed-meshheading:9138036-Immunoglobulin A,
pubmed-meshheading:9138036-Immunoglobulin G,
pubmed-meshheading:9138036-Immunoglobulin M,
pubmed-meshheading:9138036-Immunosuppression,
pubmed-meshheading:9138036-Interferon-gamma,
pubmed-meshheading:9138036-Interleukin-4,
pubmed-meshheading:9138036-Intestines,
pubmed-meshheading:9138036-Mice,
pubmed-meshheading:9138036-Mice, Inbred C57BL,
pubmed-meshheading:9138036-Time Factors,
pubmed-meshheading:9138036-beta-Glucans
|
pubmed:year |
1997
|
pubmed:articleTitle |
beta-(1-->3, 1-->4) oat glucan enhances resistance to Eimeria vermiformis infection in immunosuppressed mice.
|
pubmed:affiliation |
Department of Animal and Poultry Science, University of Saskatchewan, Saskatoon, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|